| |
| |
|
| Insider
Information: |
Bisaro Paul |
| Relationship: |
Director |
| City: |
Blauvelt |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
315,883 |
|
|
Indirect Shares
|
120,000 |
|
|
| Direct
Value |
$55,221,764 |
|
|
|
Indirect Value
|
$23,162,400 |
|
|
| Total
Shares |
435,883 |
|
|
| Total
Value |
$78,384,164 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
1
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
 -46.3%
|
 55.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Allergan plc |
AGN |
Director |
2018-05-02 |
263,729 |
2018-05-02 |
120,000 |
Premium* |
|
|
Zoetis Inc. |
ZTS |
Director |
2024-02-10 |
21,782 |
2018-05-01 |
0 |
Premium* |
|
|
Therapeuticsmd Inc |
TXMD |
Director |
2022-08-18 |
5,922 |
2020-06-04 |
0 |
Premium* |
|
|
Myriad Genetics Inc |
MYGN |
Director |
2023-06-01 |
24,450 |
2022-10-31 |
0 |
Premium* |
|
|
Mallinckrodt plc |
MNK |
Director |
2023-11-14 |
0 |
2023-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGN |
Allergan plc |
Chair,Pres &CEO |
• • – |
2013-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
440,916 |
440,916 |
0 |
- |
|
| AGN |
Allergan plc |
Chair,Pres &CEO |
• • – |
2013-11-11 |
4 |
S |
$158.48 |
$6,495,569 |
D/D |
(40,921) |
399,995 |
0 |
- |
|
| AGN |
Allergan plc |
Chair,Pres &CEO |
• • – |
2014-05-09 |
4 |
A |
$197.05 |
$2,000,058 |
D/D |
10,150 |
410,145 |
0 |
- |
|
| AGN |
Allergan plc |
Exec Chairman |
• • – |
2015-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,702 |
422,531 |
0 |
- |
|
| AGN |
Allergan plc |
Exec Chairman |
• • – |
2015-03-05 |
4 |
D |
$295.70 |
$914,304 |
D/D |
(3,092) |
420,755 |
0 |
- |
|
| AGN |
Allergan plc |
Exec Chairman |
• • – |
2015-07-31 |
4 |
GD |
$0.00 |
$0 |
I/I |
120,000 |
120,000 |
0 |
- |
|
| AGN |
Allergan plc |
Exec Chairman |
• • – |
2015-08-24 |
4 |
B |
$297.42 |
$297,422 |
D/D |
1,000 |
421,755 |
2.81 |
- |
|
| AGN |
Allergan plc |
Exec Chairman |
• • – |
2017-02-01 |
4 |
D |
$229.32 |
$782,211 |
D/D |
(3,411) |
185,456 |
0 |
- |
|
| AGN |
Allergan plc |
Exec Chairman |
• • – |
2017-02-01 |
4 |
A |
$229.32 |
$1,629,319 |
D/D |
7,105 |
188,867 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2017-02-02 |
4 |
A |
$229.52 |
$101,907 |
D/D |
444 |
305,900 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2017-03-02 |
4 |
S |
$245.73 |
$17,267,561 |
D/D |
(70,000) |
235,900 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2017-03-05 |
4 |
D |
$245.63 |
$702,993 |
D/D |
(2,862) |
233,038 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2017-05-03 |
4 |
D |
$243.76 |
$52,165 |
D/D |
(214) |
232,824 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2017-05-04 |
4 |
A |
$245.25 |
$299,941 |
D/D |
1,223 |
234,047 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2017-10-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,727 |
271,774 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2017-12-29 |
4 |
D |
$163.58 |
$1,066,705 |
D/D |
(6,521) |
265,253 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2018-03-05 |
4 |
D |
$148.73 |
$434,440 |
D/D |
(2,921) |
262,332 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2018-05-01 |
4 |
D |
$152.94 |
$89,929 |
D/D |
(588) |
261,744 |
0 |
- |
|
| ZTS |
Zoetis Inc. |
Director |
– • – |
2018-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,894 |
3,894 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2018-05-02 |
4 |
A |
$151.07 |
$299,874 |
D/D |
1,985 |
263,729 |
0 |
- |
|
| ZTS |
Zoetis Inc. |
Director |
– • – |
2019-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,150 |
8,044 |
0 |
- |
|
| ZTS |
Zoetis Inc. |
Director |
– • – |
2020-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,704 |
11,748 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2020-06-04 |
4 |
B |
$1.14 |
$57,000 |
D/D |
50,000 |
50,000 |
2.39 |
% |
|
| ZTS |
Zoetis Inc. |
Director |
– • – |
2021-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,779 |
14,527 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2021-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,864 |
146,864 |
0 |
- |
|
38 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
